Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Biological & Pharmaceutical Bulletin|January 12, 2026
Exploratory Analysis for Development Predictive Models of Immune Checkpoint Inhibitor-Induced Myocarditis Using a Nationwide Claims DatabaseReina Yamamoto, Hirofumi Hamano, Koki Nakagomi, et al.DEN Open|May 12, 2025
Adequacy evaluation of 22-gauge needle endoscopic ultrasound-guided tissue acquisition samples and glass slides preparation for successful comprehensive genomic profiling testing: A single institute experienceTami Nagatani, Yoji Wani, Masahiro Takatani, et al.Cancer Chemotherapy and Pharmacology|December 7, 2011
Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumorsYoshitaka Seki, Noboru Yamamoto, Yosuke Tamura, et al.BMC Cancer|January 14, 2022
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective studyShigemasa Takamizawa, Tatsunori Shimoi, Natsuko Satomi-Tsushita, et al.Breast Cancer Research and Treatment|June 4, 2020
Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adultsTomoko Watanabe, Takayuki Honda, Hirohiko Totsuka, et al.Medicine|September 22, 2020
Survival outcomes in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer administered a therapy following trastuzumab emtansine treatmentRurina Watanuki, Akihiko Shimomura, Shu Yazaki, et al.Investigational New Drugs|July 13, 2011
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancerYasushi Goto, Ikuo Sekine, Maki Tanioka, et al.Journal of Bone Oncology|September 9, 2017
Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acidMasashi Yanae, Shinichiro Fujimoto, Kaori Tane, et al.Cancers|July 29, 2025
Definitions of, Advances in, and Treatment Strategies for Breast Cancer OligometastasisTadahiko Shien, Shogo Nakamoto, Yuki Fujiwara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 22, 2019
[Ifosfamide and Paclitaxel for Recurrent or Metastatic Uterine Carcinosarcoma]Yohei Ohtake, Kazuki Sudo, Yuki Kojima, et al.Pageof 5